2021-01-04,Phio Pharmaceuticals to Participate in the H.C. Wainwright BioConnect 2021 Conference
2020-11-19,Phio Pharmaceuticals to Participate in the 3rd Annual Evercore ISI HealthCONx Conference
2020-11-10,Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-09,Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment
2020-10-26,Phio Pharmaceuticals Announces Three Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
2020-09-09,Phio Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-08-25,PHIO: Intratumoral Intasyl Reprograms T Cells
2020-08-12,Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-06-22,Phio Presents Additional Data Supporting Potential of TIGIT Targeting INTASYL Compound in the Tumor Microenvironment at AACR 2020
2020-06-15,PHIO: Roussys Robert Details Developments in Melanoma Medicine
2020-06-08,"Phio Pharmaceuticals to Host Key Opinion Leader Call on Intratumoral Therapy with Self-Delivering RNAi on Friday, June 12th"
2020-05-29,Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity
2020-05-29,PHIO: Intasyl Advantage vs. Gene Editing
2020-05-14,Phio Presents Data on INTASYL as an Alternative to Genetic Modification to Improve Cell-based Immunotherapy at ASGCT 2020
2020-05-12,Phio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-04,Phio to Present at Upcoming Medical Meetings and Investor Conference in Spring 2020
2020-04-07,PHIO: Collaborations Provide Several Options
2020-04-02,Phio Pharmaceuticals Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market
2020-03-31,Phio Pharmaceuticals Announces $4.0 Million Registered Direct Offering Priced At-the-Market
2020-03-31,Phio Announces Positive New Data Validating the INTASYL Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth
2020-03-26,Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update
2020-03-11,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment"
2020-03-10,Phio Pharmaceuticals and Helmholtz Zentrum M端nchen Announce Collaboration and Option Agreement with Medigene
2020-02-13,Phio Pharmaceuticals Announces Closing of $8.0 Million Underwritten Public Offering
2020-02-12,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data"
2020-02-11,Phio Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
2020-02-10,Phio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements
2020-02-06,Phio Pharmaceuticals Announces Closing of $1.74 Million Registered Direct Offering Priced At-the-Market
2020-02-05,Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-Market
2020-01-14,Phio Pharmaceuticals Announces Reverse Stock Split
2020-01-06,Phio Pharmaceuticals to Present at Biotech Showcase 2020
2019-12-13,Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
2019-11-21,Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors
2019-11-20,Phio Pharmaceuticals Announces Closing of Public Offering of Common Stock
2019-11-19,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout"
2019-11-18,Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock
2019-11-13,Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock
2019-11-13,Does Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Have A Particularly Volatile Share Price?
2019-11-13,PHIO: Third Quarter 2019 Financial & Operational Update
2019-11-12,Phio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-10-29,Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019
2019-10-11,Phio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of Stockholders
2019-09-09,Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
2019-09-03,Phio Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Healthcare Conference
2019-08-26,PHIO: Overcoming Immune Checkpoints
2019-08-15,Phio Pharmaceuticals and Helmholtz Zentrum M端nchen to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics
2019-08-12,Phio Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
2019-06-12,PHIO: Two Compounds Entering Clinic in 2020
2019-05-20,Phio Pharmaceuticals to Present at Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum
2019-05-14,Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights
2019-04-22,PHIO: Activation in the Tumor Microenvironment
2019-04-12,"After name change, Phio Pharma 'reinvents' gene-silencing pipeline"
2019-04-10,Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
2019-03-28,Phio and Glycostem to Collaborate on Use of its sd-rxRNA速 platform and Glycostem's oNKord速 Cell Therapy Products for the Next Generation of Natural Killer Cell-based Immunotherapy for Cancer Treatment
2019-03-27,Phio Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Highlights
2019-03-25,Phio Pharmaceuticals to Present Poster on the Use of Self-Delivering RNAi in Immuno-oncology at the AACR Annual Meeting 2019
2019-02-15,Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
2018-12-18,Phio Pharmaceuticals to Present at Biotech Showcase 2019 in San Francisco
2018-12-04,Phio Pharmaceuticals to Present at the Tumor Targeted Lymphocytes Summit in Boston on December 13
2018-12-03,PHIO: Soldiering On as We Wait for Bids
2018-11-19,RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
